Google's life-sciences subsidiary, Verily, plans to release millions of male mosquitoes in Florida and California to suppress populations that carry deadly diseases [1], [3].
The initiative aims to reduce the transmission of mosquito-borne illnesses, including the West Nile virus, dengue, and Zika, by disrupting the breeding cycle of the insects [1], [3].
Verily is seeking federal approval in 2024 to implement the program [1], [3]. The company intends to release male mosquitoes that have been infected with Wolbachia bacteria [1]. These lab-altered mosquitoes are non-biting, meaning they do not pose a direct risk of transmitting diseases to humans [1].
There are conflicting reports regarding the exact scale of the release. Some estimates indicate the company plans to release up to 32 million male mosquitoes [1]. Other reports suggest the number could be as high as 64 million [5].
The program targets specific regions in Florida and California where the risk of disease transmission is high [2], [4]. By introducing Wolbachia-infected males into the wild, the program seeks to lower the overall population of disease-carrying mosquitoes over time [1], [5].
While some reports describe the insects as genetically modified [6], the primary method cited is the introduction of the Wolbachia bacteria to inhibit the reproduction of the target species [1]. This biological approach is designed to curb the spread of illnesses following confirmed reports of the West Nile virus in affected areas [3].
“Verily is seeking federal approval in 2024 to implement the program.”
The use of Wolbachia bacteria represents a shift toward biological population control rather than traditional chemical insecticides. By targeting the reproductive success of mosquitoes, Google's Verily is attempting to create a sustainable reduction in disease vectors, which could provide a blueprint for managing public health crises in other tropical or subtropical regions.
